Axsome to send Alzheimer's disease drug to FDA
Hosted on MSN1h
Axsome Therapeutics Stock Tumbles As Alzheimer's Studies Reveal Mixed Results: Retail Sentiment Remains BullishShares of Axsome Therapeutics (AXSM) fell over 11% in Monday morning trade after it posted mixed results of its Alzheimer’s ...
Caregivers in Arizona experience the heavy burden of Alzheimer's, with unpaid care valued at $10.2 billion annually.
Dr Karan Rajan, an NHS surgeon and University of Sunderland lecturer, has shared his thoughts on 'menstrual blood-derived ...
NA-831 is under clinical development by Biomed Industries and currently in Phase III for Alzheimer’s Disease. According to GlobalData, Phase III drugs for Alzheimer’s Disease have a 12% phase ...
FOX 13 Tampa Bay on MSN4d
Remembering loved ones lost to Alzheimer's disease during the holidaysTAMPA, Fla. - Every year, about 500,000 people are diagnosed with Alzheimer's disease. For many, the holidays are a key time ...
Dec. 19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease in a subset of people.
Pepinemab is under clinical development by Vaccinex and currently in Phase II for Alzheimer’s Disease. According to GlobalData, Phase II drugs for Alzheimer’s Disease have a 36% phase transition ...
Nearly 80% of caregiving for people with Alzheimer’s disease or dementia occurs in the home but most caregivers don’t realize ...
During this late-stage Alzheimer’s, laugh, sing Christmas carols together, pray. While keeping connected with the affected ...
Atlanta News First on MSN23h
Buckhead woman with Alzheimer’s disease goes missing while walking dog, police sayAtlanta police are looking for a missing woman with Alzheimer’s disease who was last seen walking her dog on Sunday morning.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback